InspireMD, Inc. (NSPR)

InspireMD Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	9.64	4.63	12	12.65	5.51
Short-Term Investments	29.38	13.17	22.04	0	0
Cash & Cash Equivalents	39.02	17.8	34.04	12.65	5.51
Cash Growth	119.19%	-47.70%	169.20%	129.33%	-41.24%
Receivables	2.45	1.25	1.39	0.62	0.97
Inventory	2.11	1.62	1.14	1.42	1.24
Other Current Assets	0.58	0.66	0.52	0.66	0.09
Total Current Assets	44.16	21.33	37.09	15.34	7.81
Property, Plant & Equipment	2.53	2.47	1.71	1.71	1.48
Other Long-Term Assets	0.95	0.86	0.91	0.73	0.59
Total Long-Term Assets	3.48	3.33	2.62	2.44	2.07
Total Assets	47.64	24.65	39.71	17.78	9.88
Accounts Payable	6.02	5.07	4.35	3.71	3.12
Total Current Liabilities	6.02	5.07	4.35	3.71	3.12
Long-Term Debt	1.04	1.2	0.78	1	0.65
Other Long-Term Liabilities	1.08	1	1.05	0.91	0.73
Total Long-Term Liabilities	2.12	2.19	1.83	1.91	1.38
Total Liabilities	8.14	7.26	6.18	5.61	4.5
Total Debt	1.04	1.2	0.78	1	0.65
Debt Growth	-13.14%	53.01%	-21.82%	52.99%	-
Retained Earnings	-221.5	-201.59	-183.09	-168.18	-157.63
Shareholders' Equity	39.5	17.39	33.53	12.16	5.38
Net Cash / Debt	37.99	16.61	33.26	11.65	4.86
Net Cash / Debt Growth	128.72%	-50.06%	185.58%	139.58%	-48.20%
Net Cash Per Share	1.57	2.11	4.53	7.70	34.89
Working Capital	38.14	16.26	32.75	11.63	4.7
Book Value Per Share	1.63	2.21	4.57	8.04	38.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).